Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob and TipCAT micro-robotic technologies, is developing two product candidates, including the Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; and a self-propelling, semi-disposable endoscope, which is used in colonoscopy procedures. It also holds an intellectual property portfolio that comprises 9 patent families, which include 9 patents granted in the United States, 12 patents granted outside the United States, and 15 patent applications pending worldwide. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
Industry, Sector and Symbol
Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Phone781-875-3605
Debt
Current Ratio12.44
Quick Ratio12.44
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Price / Cash FlowN/A
Price / Book2.24
Profitability
Net Income$-7,580,000.00
Net MarginsN/A
Return on Assets-73.30%
Miscellaneous
Employees7
OptionableNot Optionable
Microbot Medical (NASDAQ:MBOT) Frequently Asked Questions
What is Microbot Medical's stock symbol?
Microbot Medical trades on the NASDAQ under the ticker symbol "MBOT."
When did Microbot Medical's stock split? How did Microbot Medical's stock split work?
Shares of Microbot Medical reverse split on the morning of Monday, May 9th 2016. The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 6th 2016. An investor that had 100 shares of Microbot Medical stock prior to the reverse split would have 8 shares after the split.
How were Microbot Medical's earnings last quarter?
Microbot Medical Inc (NASDAQ:MBOT) released its quarterly earnings data on Wednesday, November, 14th. The biotechnology company reported ($0.58) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.60) by $0.02. View Microbot Medical's Earnings History.
When is Microbot Medical's next earnings date?
What price target have analysts set for MBOT?
1 brokers have issued 1 year target prices for Microbot Medical's shares. Their forecasts range from $1.75 to $1.75. On average, they expect Microbot Medical's share price to reach $1.75 in the next twelve months. This suggests that the stock has a possible downside of 80.7%. View Analyst Price Targets for Microbot Medical.
What is the consensus analysts' recommendation for Microbot Medical?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Microbot Medical in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Microbot Medical.
Has Microbot Medical been receiving favorable news coverage?
News headlines about MBOT stock have been trending somewhat positive recently, InfoTrie reports. The research group identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Microbot Medical earned a news impact score of 1.9 on InfoTrie's scale. They also gave news coverage about the biotechnology company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the next several days.
Who are some of Microbot Medical's key competitors?
Some companies that are related to Microbot Medical include TRACON Pharmaceuticals (TCON), Vical (VICL), CytRx (CYTR), Titan Pharmaceuticals (TTNP), Windtree Therapeutics (WINT), Mymetics (MYMX), aTyr Pharma (LIFE), Vaxart (VXRT), Aevi Genomic Medicine (GNMX), Genetic Technologies (GENE), TrovaGene (TROV), Enzon Pharmaceuticals (ENZN), Neuralstem (CUR), Mateon Therapeutics (MATN) and Vitro Diagnostics (VODG).
Who are Microbot Medical's key executives?
Microbot Medical's management team includes the folowing people:
- Mr. Harel Gadot, Co-Founder, Pres, CEO & Chairman (Age 45)
- Prof. Moshe Shoham, Co-Founder, Scientific Director & Member of Scientific Advisory Board (Age 66)
- Mr. Yoseph Bornstein, Co-Founder & Director (Age 59)
- Mr. David Ben Naim CPA, M.B.A., Chief Financial Officer (Age 49)
- Mr. Yehezkel Himelfarb, COO, GM of Israeli operations & Director (Age 60)
How do I buy shares of Microbot Medical?
Shares of MBOT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Microbot Medical's stock price today?
One share of MBOT stock can currently be purchased for approximately $9.08.
How big of a company is Microbot Medical?
Microbot Medical has a market capitalization of $7.23 million. Microbot Medical employs 7 workers across the globe.
What is Microbot Medical's official website?
How can I contact Microbot Medical?
Microbot Medical's mailing address is 25 RECREATION PARK DRIVE UNIT 108, HINGHAM MA, 02043. The biotechnology company can be reached via phone at 781-875-3605 or via email at [email protected]
MarketBeat Community Rating for Microbot Medical (NASDAQ MBOT)
MarketBeat's community ratings are surveys of what our community members think about Microbot Medical and other stocks. Vote "Outperform" if you believe MBOT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MBOT will underperform the S&P 500 over the long term. You may vote once every thirty days.
